XWL
IDXX icon

XXI Wealth LLC’s Idexx Laboratories IDXX Stock Holding History

XXI Wealth LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
515
+44
+9% +$24.7K 0.12% 182
2026
Q1 		$265K Sell
471
-231
-33% -$148K 0.15% 167
2025
Q4 		$475K Buy
+702
New +$478K 0.29% 86

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

XXI Wealth LLC's IDXX Position: Q2 2026 in Review

XXI Wealth LLC increased its Idexx Laboratories (IDXX) stake by 9.3% in Q2 2026, buying an estimated $24.7K and bringing the position to 515 shares worth $271K. The position accounts for 0.12% of the portfolio, ranked #182.

XXI Wealth LLC first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $475K in Q4 2025. 1,297 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • XXI Wealth LLC held 515 shares of Idexx Laboratories worth $271K as of Q2 2026.
  • XXI Wealth LLC bought 44 Idexx Laboratories shares in Q2 2026, an estimated $24.7K.
  • Idexx Laboratories made up 0.12% of XXI Wealth LLC's portfolio in Q2 2026, its #182 holding.
  • XXI Wealth LLC first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • XXI Wealth LLC's Idexx Laboratories position peaked at $475K in Q4 2025.
  • 1,297 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.